Placental origins of angiogenic dysfunction in mirror syndrome

Hypertension in Pregnancy

Volumn 31, Issue 2, 2012, Pages 211-217

  Bixel, Kristin ^a   Silasi, Michelle ^a   Zelop, Carolyn M ^a   Lim, Kee Hak ^a   Zsengeller, Zsuzsanna ^b   Stillman, Isaac E ^b   Rana, Sarosh ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

Angiogenic imbalance; Mirror syndrome; Preeclampsia; SFlt1

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; MAGNESIUM SULFATE; PLACENTAL GROWTH FACTOR;

ADULT; AMNIOCENTESIS; ANTIANGIOGENIC ACTIVITY; ARTICLE; ASCITES; BLOOD GROUP AB; CASE REPORT; CYSTIC LYMPHANGIOMA; CYTOMEGALOVIRUS; DILATION AND EVACUATION; DYSPNEA; FEMALE; FETUS HYDROPS; GESTATIONAL AGE; HUMAN; HYPERTENSION; HYPERTRANSAMINASEMIA; IMMUNOHISTOCHEMISTRY; LEG EDEMA; MIRROR SYNDROME; NEOVASCULARIZATION (PATHOLOGY); PERICARDIAL EFFUSION; PLACENTA DISORDER; PLEURA EFFUSION; PREECLAMPSIA; PREGNANCY DISORDER; PROTEINURIA; SEIZURE; SKINFOLD THICKNESS; WEIGHT GAIN;

ADULT; ANTIGENS, CD; BIOLOGICAL MARKERS; FEMALE; HUMANS; HYDROPS FETALIS; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY PROTEINS; RECEPTORS, CELL SURFACE; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 84861091715     PISSN: 10641955     EISSN: 15256065     Source Type: Journal    
DOI: 10.3109/10641955.2011.638959     Document Type: Article

References (23)

1. Ballantyne J. The Disease and Deformities of the Fetus. Edinburgh: Oliver & Boyd, 1892.
2. Braun T, Brauer M, Fuchs I, et al. Mirror syndrome: A systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther 2010; 27(4): 191-203.
3. Chang YL, Chao AS, Hsu JJ, Chang SD, Soong YK. Selective fetocide reversed mirror syndrome in a dichorionic triplet pregnancy with severe twin-twin transfusion syndrome: A case report. Fetal Diagn Ther 2007; 22(6): 428-430.
4. Livingston JC, Malik KM, Crombleholme TM, Lim FY, Sibai BM. Mirror syndrome: A novel approach to therapy with fetal peritoneal-amniotic shunt. Obstet Gynecol 2007; 110 (2 Pt 2): 540-543. (Pubitemid 47417758)
5. Midgley DY, Harding K. The Mirror syndrome. Eur J Obstet Gynecol Reprod Biol 2000; 88(2): 201-202. (Pubitemid 30004062)
6. Valsky DV, Daum H, Yagel S. Reversal of mirror syndrome after prenatal treatment of Diamond-Blackfan anemia. Prenat Diagn 2007; 27(12): 1161-1164. (Pubitemid 350250596)
7. Goeden AM, Worthington D. Spontaneous resolution of mirror syndrome. Obstet Gynecol 2005; 106(5 Pt 2): 1183-1186. (Pubitemid 41532875)
8. Duthie SJ, Walkinshaw SA. Parvovirus associated fetal hydrops: Reversal of pregnancy induced proteinuric hypertension by in utero fetal transfusion. Br J Obstet Gynaecol 1995; 102(12): 1011-1013. (Pubitemid 26015000)
9. Matsubara M, Nakata M, Murata S, Miwa I, Sumie M, Sugino N. Resolution of mirror syndrome after successful fetoscopic laser photocoagulation of communicating placental vessels in severe twin-twin transfusion syndrome. Prenat Diagn 2008; 28(12): 1167-1168.
10. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004; 350(7): 672-683. (Pubitemid 38364626)
11. Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003; 111(5): 649-658. (Pubitemid 36278583)
12. Rana S, Venkatesha S, DePaepe M, Chien EK, Paglia M, Karumanchi SA. Cytomegalovirusinduced mirror syndrome associated with elevated levels of circulating antiangiogenic factors. Obstet Gynecol 2007; 109(2 Pt2): 549-552. (Pubitemid 46146857)
13. Stepan H, Faber R. Elevated sFlt1 level and preeclampsia with parvovirus-induced hydrops. N Engl J Med 2006; 354(17): 1857-1858.
14. Espinoza J, Romero R, Nien JK, et al. A role of the anti-angiogenic factor sVEGFR-1 in the 'mirror syndrome' (Ballantyne's syndrome). J Matern Fetal Neonatal Med 2006; 19(10): 607-613. (Pubitemid 44804787)
15. Levine RJ, Lam C, Qian C, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 2006; 355(10): 992-1005. (Pubitemid 44343543)
16. Kanter D, Lindheimer MD, Wang E, et al. Angiogenic dysfunction in molar pregnancy. Am J Obstet Gynecol 2010; 202(2): 184.e1-184.e5.
17. Prefumo F, Pagani G, Fratelli N, Benigni A, Frusca T. Increased concentrations of antiangiogenic factors in mirror syndrome complicating twin-to-twin transfusion syndrome. Prenat Diagn 2010; 30(4): 378-379.
18. Stepan H, Faber R. Cytomegalovirus-induced mirror syndrome associated with elevated levels of angiogenic factors. Obstet Gynecol 2007; 109(5): 1205-1206. (Pubitemid 46685974)
19. Genbacev O, Zhou Y, Ludlow JW, Fisher SJ. Regulation of human placental development by oxygen tension. Science 1997; 277(5332): 1669-1672. (Pubitemid 27446230)
20. Nagamatsu T, Fujii T, Kusumi M, et al. Cytotrophoblasts up-regulate soluble fms-like tyrosine kinase-1 expression under reduced oxygen: An implication for the placental vascular development and the pathophysiology of preeclampsia. Endocrinology 2004; 145(11): 4838-4845. (Pubitemid 39551100)
21. Karumanchi SA, Bdolah Y. Hypoxia and sFlt-1 in preeclampsia: The "chicken-and-egg" question. Endocrinology 2004; 145(11): 4835-4837. (Pubitemid 39551099)
22. Nevo O, Soleymanlou N, Wu Y, et al. Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1. Am J Physiol Regul Integr Comp Physiol 2006; 291(4): R1085-R1093. (Pubitemid 44498450)
23. Bdolah Y, Lam C, Rajakumar A, et al. Twin pregnancy and the risk of preeclampsia: Bigger placenta or relative ischemia? Am J Obstet Gynecol 2008; 198(4): 428.e1-428.e6.